Assertio Holdings, Inc.

NASDAQ:ASRT

Drug Manufacturers - Specialty & Generic

Healthcare
$23.50 +0.04%

+$0.01 today

Market cap
$151.86M
Beta
0.53
P/E (TTM)
-4.2
EPS (TTM)
-$5.55
52W Low $8.61High $23.50

Volume 0.27M

Average 0.33M

ASRT Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

Assertio Holdings, Inc.NASDAQ: ASRT

Retained Earnings · Q1 FY2026 · quarter ended Mar 2026

Retained earnings remains negative

Q1 FY2026 retained earnings was -$722.36M, compared with -$686.67M a year earlier.

Context

  • Retained earnings amounted to 341.9% of total assets at the end of Q1 FY2026, up 102.1 pp from a year earlier.
  • Retained earnings grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether retained earnings keeps falling in the next quarterly balance sheet after a -5.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$722.36M-2.7% QoQ
Last fiscal yearDec 2025
-$703.5M-4.5% YoY
Year agoMar 2025
-$686.67M-5.2% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-5.2%——
1 year-4.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

USD · from the balance sheet

Latest · FY2025
(703.5M) USD
Year-over-year change
-4.5%

Retained Earnings vs competitors

How ASRT compares with its peers on the latest reported figures

  • Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -5.2% is the 3rd highest of 10, against a peer median of -20.3%.
  • Retained earnings amounts to 341.9% of total assets for ASRT, versus a peer median of 264.1%.
ASRT Competitors
Retained Earnings for ASRT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NTRBNutriband Inc.Apr 2026-$47.93M USD-20.3%—695.5%
XBITXBiotech Inc.Mar 2026-$141.88M USD-39.5%—101.5%
ACRVAcrivon Therapeutics, Inc. Common StockMar 2026-$293.92M USD-35.7%—272.6%
INCRInterCure Ltd.Dec 2025-₪314.62M ILS-13.3%—45.6%
VXRTVaxart, Inc.Mar 2026-$455.02M USD+7.5%—252.7%
PMVPPMV Pharmaceuticals, Inc.Mar 2026-$464.49M USD-20.3%—481.0%
TCRXTScan Therapeutics, Inc.Mar 2026-$533.53M USD-30.4%—264.1%
LUNGPulmonx CorporationMar 2026-$535.21M USD-11.0%—446.1%
FBIOFortress Biotech, Inc.Mar 2026-$623.68M USD+17.0%—174.8%
ASRTAssertio Holdings, Inc.Mar 2026-$722.36M USD-5.2%—341.9%
Peer median (excluding ASRT) —-20.3%—264.1%

Competitors are the stored peer set for ASRT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents36.81M64.94M73.44M50.59M10.23M
Short-term Investments00049.47M53.18M
Net Receivables43.75M45.36M47.66M54.12M120.11M
Inventory7.49M13.7M37.69M38.31M24.12M
Other Current Assets608K0299K10.07M9.01M
Total Current Assets103.5M132.26M171.06M202.55M216.65M
Property, Plant & Equipment (Net)2.26M881K2.04M1.71M444K
Goodwill00000
Intangible Assets216.05M198M111.33M80.47M48.91M
Long-term Investments1.58M268K000
Tax Assets080.2M000
Other Non-current Assets3.15M2.3M1.99M1K972K
Total Non-current Assets223.05M281.65M115.36M82.18M50.32M
Total Assets326.55M413.91M286.42M284.73M266.97M
Account Payables6.69M5.99M13.44M14.74M9.01M
Short-term Debt12.17M470K000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities47.65M30.37M6.09M96.36M118.5M
Total Current Liabilities135.02M95.32M93.44M114.69M127.51M
Long-term Debt61.32M66.4M38.21M38.81M39.12M
Deferred Tax Liabilities04.27M4.55M02.42M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities27.4M22.2M10.74M9.03M3.08M
Total Non-current Liabilities89.11M92.87M54.97M48.96M45.51M
Total Liabilities224.13M188.19M148.42M163.65M173.02M
Common Stock4K5K9K9K1K
Retained Earnings(429.23M)(319.6M)(651.54M)(673.12M)(703.5M)
Accumulated OCI00000
Other Stockholders Equity10000
Minority Interest00000
Total Equity102.41M225.73M138M121.08M93.95M
Total Debt75.87M66.87M39.68M40.27M40.01M
Net Debt39.06M1.93M(33.77M)(10.32M)29.78M

Assertio Holdings, Inc.

NASDAQ:ASRT

Intrinsic Alpha fair value

Locked

Current Price

$23.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.